Vismodegib in PAMAM-dendrimers for potential theragnosis in skin cancer-Reference-Cited by-同舟云学术

Vismodegib in PAMAM-dendrimers for potential theragnosis in skin cancer

Published:2022-07 Issue: Volume:7 Page:100053
ISSN:2352-9520
Container-title:OpenNano
language:en
Short-container-title:OpenNano

Author:

Ybarra David E.,Calienni Maria Natalia,Ramirez Luis Felipe Barraza,Frias E. Tais Aguayo,Lillo Cristian,Alonso Silvia del Valle,Montanari Jorge,Alvira Fernando C.^ORCID

Funder

Fondo Nacional de Desarrollo Científico y Tecnológico

Consejo Nacional de Investigaciones Científicas y Técnicas

Roche Products

Universidad Nacional de Quilmes

Consejo Interuniversitario Nacional

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmaceutical Science,Biotechnology,Internal Medicine

Reference39 articles.

1. Experimental Findings about the Fluorescence Emission of Generation 4.0 and 4.5 Polyamidoamine Dendrimers

2. L.F. Barraza, V.A. Jiménez, J.B.J.T.J.o.P.C.B. Alderete, 121 (2017) 4-12.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutting-edge advancements in anticancer drug delivery and scope for theranostics using biocompatible multifunctional mesoporous silica nanoparticles;Journal of Drug Delivery Science and Technology;2024-04

2. Cutaneous Pharmacokinetics of Topically Applied Novel Dermatological Formulations;AAPS PharmSciTech;2024-02-27

3. Nanotechnology as a Promising Method in the Treatment of Skin Cancer;International Journal of Molecular Sciences;2024-02-10

4. Nanocarriers in topical photodynamic therapy;Expert Opinion on Drug Delivery;2024-02

5. A crossover study of antimicrobial capacity and biotoxicity of silver nanoparticles;Applied Organometallic Chemistry;2024-01-24